Six-patient trial shows signs of retinal protection: AI analysis helps assess nonviral gene therapy
PST-611 aims to slow retinal damage caused by geographic atrophy by regulating iron balance. Images from six patients show preliminary changes, but post hoc analysis and short-term follow-up are not yet sufficient to prove that the therapy can preserve vision.